secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adverum Biotechnologies, Inc. (—)
CIK:        0001501756
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001193125-24-072709
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adverum Biotechnologies files 1-for-10 reverse stock split effective March 21, 2024
--------------------------------------------------------------------------------

- Board approved 1-for-10 reverse split on March 8; Certificate of Amendment filed March 20, effective 12:01 a.m. ET March 21.
- Every 10 shares of common stock convert to 1 share; par value per share unchanged.
- Total authorized shares remain 300 million; no fractional shares issued (cash in lieu).
- Restated Certificate of Incorporation filed (restates but does not further amend), effective 12:02 a.m. ET March 21.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501756/000119312524072709/0001193125-24-072709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501756/000119312524072709/d814195d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-072709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer